As crucial regulators of local immune responses and tissue repair, macrophages in diabetic wounds show dysregulated switching from M1 to M2, resulting in a poor regenerative environment, exacerbated tissue damage, and delayed wound healing 63
This is the one that matters most here, because SCFAs are the link to GLP-1
The long half-life means that even after stopping treatment, side effects can persist for several weeks
Yet current prescribing guidelines dont recommend asking a basic question before initiating treatment: Does this patient actually have low endogenous GLP-1 levels
To put that into perspective, the average weight loss with Wegovy (semaglutide 2.4 mg) is around 17.5% over 68 weeks, and with Mounjaro (tirzepatide 15 mg), around 20% over 72 weeks